Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005)
- Status
- COMPLETED
- Phase
- PHASE1
Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Trial for Chemo-Resistant Gestational Trophoblastic Neoplasias With Pembrolizumab (CR-GTP)
- Status
- UNKNOWN
- Phase
- PHASE2
Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pharmacokinetics of Islatravir in Participants With Severe Renal Impairment (MK-8591-026)
- Status
- COMPLETED
- Phase
- PHASE1
Doravirine/Islatravir (DOR/ISL) in Pediatric Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are <18 Years of Age and Weigh ≥35 kg (MK-8591A-028)
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of BJ-001, an IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Use of an Educational Multimedia Tool Versus Routine Care for the Uptake of Postpartum LARC in High-Risk Pregnancies
- Status
- UNKNOWN
- Phase
- NA
Ovarian Function With ENG Implant and UPA Use
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cytomegalovirus Infection in Critically Ill Patients and Patients Receiving Anticancer Therapy
- Status
- UNKNOWN
- Phase
- N/A
A Phase Ib Combination Study of Rituximab, TinostamustinEAnd CHeckpoint Inhibition With Pembrolizumab in Relapsed/Refractory DLBCL
- Status
- WITHDRAWN
- Phase
- PHASE1
HPV Vaccination Study in Postpartum Women
- Status
- COMPLETED
- Phase
- PHASE4
Pembrolizumab in MarginalzoneLymphoma A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY
- Status
- TERMINATED
- Phase
- PHASE2
Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)
- Status
- TERMINATED
- Phase
- PHASE2
Microbiota and Bone Fragility:Study of the Relation Between Gut Microbiota and Bone Microarchitecture
- Status
- COMPLETED
- Phase
- NA
Applying Best Clinical Practices to Patients at High Risk of Respiratory Complications
- Status
- COMPLETED
- Phase
- PHASE4
The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2